Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Metformin to Prevent the Metabolic Complications of Olanzapine.

Trial Profile

Metformin to Prevent the Metabolic Complications of Olanzapine.

Phase of Trial: Phase IV

Latest Information Update: 11 Dec 2012

At a glance

  • Drugs Metformin (Primary) ; Olanzapine
  • Indications Metabolic syndrome
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 17 Aug 2012 Actual end date (1 Aug 2011) added as reported by ClinicalTrials.gov.
    • 01 Aug 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 16 Sep 2010 Planned end date changed from 1 Aug 2010 to 1 Aug 2011 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top